Loading...
•
Mar 31, 2023
Enovis Q1 2023 Earnings Report
Enovis experienced a strong start to the year, marked by sales growth, organic growth, and EBITDA margin expansion.
Key Takeaways
Enovis reported strong Q1 2023 results with 8% sales growth and 9% organic growth. The Reconstructive segment grew by 19% organically, while the Prevention and Recovery segment grew by 4% organically. The company's adjusted EPS was $0.44, and they have increased their 2023 financial outlook.
Sales grew 8% and organic growth was 9%.
Reconstructive segment experienced 19% organic growth.
Prevention and Recovery segment saw 4% organic growth.
Adjusted earnings per diluted share reached $0.44.
Enovis
Enovis
Forward Guidance
Enovis updated its financial expectations for 2023.
Positive Outlook
- Revenue is expected to organically grow 6-7% from the prior year versus prior expectations of 5-6% growth.
- Adjusted EBITDA is forecasted to be $259-$267 million as compared with the previous outlook of $255-265 million.
- Adjusted earnings per diluted share was updated from $2.15-$2.30 to $2.18-$2.32.